SE455671B - Flytande farmaceutisk komposition for nasal administration innefattande en kalcitonin och bensalkoniumklorid samt behallare for denna komposition - Google Patents

Flytande farmaceutisk komposition for nasal administration innefattande en kalcitonin och bensalkoniumklorid samt behallare for denna komposition

Info

Publication number
SE455671B
SE455671B SE8305485A SE8305485A SE455671B SE 455671 B SE455671 B SE 455671B SE 8305485 A SE8305485 A SE 8305485A SE 8305485 A SE8305485 A SE 8305485A SE 455671 B SE455671 B SE 455671B
Authority
SE
Sweden
Prior art keywords
nasal
composition
calcitonin
administration
composition according
Prior art date
Application number
SE8305485A
Other languages
English (en)
Swedish (sv)
Other versions
SE8305485D0 (sv
SE8305485L (sv
Inventor
Moise Azria
Thomas Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27449393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE455671(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB838320865A external-priority patent/GB8320865D0/en
Priority claimed from GB838322528A external-priority patent/GB8322528D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8305485D0 publication Critical patent/SE8305485D0/xx
Publication of SE8305485L publication Critical patent/SE8305485L/xx
Publication of SE455671B publication Critical patent/SE455671B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8305485A 1982-10-05 1983-10-05 Flytande farmaceutisk komposition for nasal administration innefattande en kalcitonin och bensalkoniumklorid samt behallare for denna komposition SE455671B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8228390 1982-10-05
GB8236928 1982-12-30
GB838320865A GB8320865D0 (en) 1983-08-03 1983-08-03 Organic compounds
GB838322528A GB8322528D0 (en) 1983-08-22 1983-08-22 Organic compounds

Publications (3)

Publication Number Publication Date
SE8305485D0 SE8305485D0 (sv) 1983-10-05
SE8305485L SE8305485L (sv) 1984-04-06
SE455671B true SE455671B (sv) 1988-08-01

Family

ID=27449393

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305485A SE455671B (sv) 1982-10-05 1983-10-05 Flytande farmaceutisk komposition for nasal administration innefattande en kalcitonin och bensalkoniumklorid samt behallare for denna komposition

Country Status (21)

Country Link
US (2) US5759565A (da)
JP (1) JPH07103043B2 (da)
AT (1) AT394947B (da)
AU (2) AU572800B2 (da)
CA (1) CA1220138A (da)
CH (1) CH657779A5 (da)
DE (1) DE3335086A1 (da)
DK (1) DK161800C (da)
FR (1) FR2533826B1 (da)
HK (1) HK27389A (da)
HU (1) HU192246B (da)
IL (1) IL69892A (da)
IT (1) IT1172324B (da)
KE (1) KE3848A (da)
MY (1) MY8700271A (da)
NL (1) NL192563C (da)
NZ (1) NZ205846A (da)
PH (1) PH22725A (da)
PT (1) PT77443B (da)
SE (1) SE455671B (da)
SG (1) SG76388G (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
CN1183965C (zh) * 2000-02-04 2005-01-12 尤尼金实验室公司 鼻内降钙素制剂
US6531112B2 (en) * 2000-05-15 2003-03-11 Delrx Pharmaceutical Corporation Formulations for administering calcitonin and processes for preparing the same
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
US7186692B2 (en) * 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
EA008829B1 (ru) * 2002-12-17 2007-08-31 Нэстек Фармасьютикал Кампани Инк. Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения
US7229966B2 (en) * 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7166575B2 (en) * 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
WO2004084859A2 (en) 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
ATE350024T1 (de) * 2003-10-15 2007-01-15 Pari Gmbh Flüssige zubereitung enthaltend tobramycin
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20100256060A1 (en) * 2009-04-02 2010-10-07 Unigene Laboratories Inc. Peptide pharmaceuticals for nasal delivery
CA2861392C (en) 2012-01-26 2021-08-17 Christopher J. Soares Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use
ES2965087T3 (es) 2016-09-02 2024-04-10 Soares Christopher J Uso de antagonistas de receptor de CGRP en el tratamiento de glaucoma
US10723716B2 (en) 2016-12-21 2020-07-28 New York University Alpha-helix mimetics as modulators of Abeta self-assembly
US11124479B2 (en) 2017-07-14 2021-09-21 New York University Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization
US10500197B2 (en) 2017-07-18 2019-12-10 New York University Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769405A (en) * 1970-04-17 1973-10-30 Armour Pharma Methods for obtaining diuresis
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
GB1354526A (en) * 1971-04-19 1974-06-05 Armour Pharma Preparation for obtaining diuresis in animals
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
JPS5625197A (en) * 1979-07-19 1981-03-10 Microbial Chem Res Found Cleomycin and its preparation
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
EP0053754B1 (de) * 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
HUT34121A (en) 1985-02-28
JPH07103043B2 (ja) 1995-11-08
CH657779A5 (de) 1986-09-30
FR2533826B1 (fr) 1987-06-12
IL69892A0 (en) 1984-01-31
HU192246B (en) 1987-05-28
AU1984983A (en) 1984-04-12
NZ205846A (en) 1987-09-30
PT77443A (en) 1983-11-01
KE3848A (en) 1989-03-31
HK27389A (en) 1989-04-07
JPH02262526A (ja) 1990-10-25
AT394947B (de) 1992-07-27
NL192563B (nl) 1997-06-02
DK458183A (da) 1984-04-06
SE8305485D0 (sv) 1983-10-05
MY8700271A (en) 1987-12-31
SE8305485L (sv) 1984-04-06
CA1220138A (en) 1987-04-07
NL8303386A (nl) 1984-05-01
DE3335086A1 (de) 1984-05-03
FR2533826A1 (fr) 1984-04-06
DK161800B (da) 1991-08-19
IL69892A (en) 1987-12-31
US5759565A (en) 1998-06-02
US5733569A (en) 1998-03-31
ATA349483A (de) 1992-01-15
DK458183D0 (da) 1983-10-04
IT8349105A0 (it) 1983-10-05
NL192563C (nl) 1997-10-03
PH22725A (en) 1988-11-28
AU2103588A (en) 1988-12-22
IT1172324B (it) 1987-06-18
AU572800B2 (en) 1988-05-19
DK161800C (da) 1992-01-27
PT77443B (en) 1986-04-11
SG76388G (en) 1989-03-23
DE3335086C2 (da) 1990-09-20

Similar Documents

Publication Publication Date Title
SE455671B (sv) Flytande farmaceutisk komposition for nasal administration innefattande en kalcitonin och bensalkoniumklorid samt behallare for denna komposition
GB2127689A (en) Calcitonin inhalation compositions
US6706255B2 (en) Liquid pharmaceutical compositions comprising thyroid hormones
US6610271B2 (en) System and method for intranasal administration of lorazepam
EP1073467B1 (en) Co-solvent formulations comprising a vitamin d compound
JP2006523630A (ja) 鼻用医薬製剤およびその使用方法
JP2020526233A (ja) 鼻炎の治療のための投与装置及び医薬組成物
CN101977588A (zh) 具有所需生物利用度的药物组合物
USRE40812E1 (en) Nasal calcitonin formulation
EP2632430A1 (en) Nasal compositions of vitamin b12
JPS5989619A (ja) カルシトニン組成物およびその用途
CN107530372A (zh) 液体胰岛素制剂及与其相关的方法
WO2017095265A1 (ru) Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения
SE445422B (sv) Farmaceutisk beredning for oral administereing innehallande 8-metoxi-furo-/3',2':6,7/-kumarin
DK174540B1 (da) Fremgangsmåde til fremstilling af et flydende farmaceutisk præparat indeholdende calcitonin og beholder indeholdende et sådant præparat
IE56601B1 (en) Galenic compositions comprising calcitonin and their use
IE56602B1 (en) Galenic compositions comprising calcitonin and their use
JPS6357527A (ja) 薬剤の吸着防止方法
US20220096438A1 (en) Methods of treating migraine
KR20020012010A (ko) 틱소코르톨 피발레이트 현탁액, 그를 기재로 한 함수제 및그를 함유하는 패키징
EP0252729A2 (en) Bronchodilatory peptides
IT9048064A1 (it) Composizioni farmaceutiche a base di calcitonina somministrabili per via nasale in terapia umana

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305485-8

Format of ref document f/p: F

NUG Patent has lapsed